Product Details for NDA 017027
LIPO-HEPIN (HEPARIN SODIUM)
1,000 UNITS/0.5ML
Marketing Status: Discontinued
1,000 UNITS/ML
Marketing Status: Discontinued
5,000 UNITS/ML
Marketing Status: Discontinued
5,000 UNITS/0.5ML
Marketing Status: Discontinued
7,500 UNITS/0.5ML
Marketing Status: Discontinued
10,000 UNITS/0.5ML
Marketing Status: Discontinued
10,000 UNITS/ML
Marketing Status: Discontinued
15,000 UNITS/0.5ML
Marketing Status: Discontinued
20,000 UNITS/ML
Marketing Status: Discontinued
20,000 UNITS/0.5ML
Marketing Status: Discontinued
40,000 UNITS/ML
Marketing Status: Discontinued
1,000 UNITS/0.5ML
Marketing Status: Discontinued
Active Ingredient: HEPARIN SODIUM
Proprietary Name: LIPO-HEPIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1,000 UNITS/0.5ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017027
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: 3M PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
LIPO-HEPIN (HEPARIN SODIUM)
Proprietary Name: LIPO-HEPIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1,000 UNITS/0.5ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017027
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: 3M PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
1,000 UNITS/ML
Marketing Status: Discontinued
Active Ingredient: HEPARIN SODIUM
Proprietary Name: LIPO-HEPIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1,000 UNITS/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017027
Product Number: 006
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: 3M PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
LIPO-HEPIN (HEPARIN SODIUM)
Proprietary Name: LIPO-HEPIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1,000 UNITS/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017027
Product Number: 006
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: 3M PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
5,000 UNITS/ML
Marketing Status: Discontinued
Active Ingredient: HEPARIN SODIUM
Proprietary Name: LIPO-HEPIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5,000 UNITS/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017027
Product Number: 008
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: 3M PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
LIPO-HEPIN (HEPARIN SODIUM)
Proprietary Name: LIPO-HEPIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5,000 UNITS/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017027
Product Number: 008
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: 3M PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
5,000 UNITS/0.5ML
Marketing Status: Discontinued
Active Ingredient: HEPARIN SODIUM
Proprietary Name: LIPO-HEPIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5,000 UNITS/0.5ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017027
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: 3M PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
LIPO-HEPIN (HEPARIN SODIUM)
Proprietary Name: LIPO-HEPIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5,000 UNITS/0.5ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017027
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: 3M PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
7,500 UNITS/0.5ML
Marketing Status: Discontinued
Active Ingredient: HEPARIN SODIUM
Proprietary Name: LIPO-HEPIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 7,500 UNITS/0.5ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017027
Product Number: 010
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: 3M PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
LIPO-HEPIN (HEPARIN SODIUM)
Proprietary Name: LIPO-HEPIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 7,500 UNITS/0.5ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017027
Product Number: 010
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: 3M PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
10,000 UNITS/0.5ML
Marketing Status: Discontinued
Active Ingredient: HEPARIN SODIUM
Proprietary Name: LIPO-HEPIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 10,000 UNITS/0.5ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017027
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: 3M PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
LIPO-HEPIN (HEPARIN SODIUM)
Proprietary Name: LIPO-HEPIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 10,000 UNITS/0.5ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017027
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: 3M PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
10,000 UNITS/ML
Marketing Status: Discontinued
Active Ingredient: HEPARIN SODIUM
Proprietary Name: LIPO-HEPIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 10,000 UNITS/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017027
Product Number: 009
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: 3M PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
LIPO-HEPIN (HEPARIN SODIUM)
Proprietary Name: LIPO-HEPIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 10,000 UNITS/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017027
Product Number: 009
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: 3M PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
15,000 UNITS/0.5ML
Marketing Status: Discontinued
Active Ingredient: HEPARIN SODIUM
Proprietary Name: LIPO-HEPIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 15,000 UNITS/0.5ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017027
Product Number: 011
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: 3M PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
LIPO-HEPIN (HEPARIN SODIUM)
Proprietary Name: LIPO-HEPIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 15,000 UNITS/0.5ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017027
Product Number: 011
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: 3M PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
20,000 UNITS/ML
Marketing Status: Discontinued
Active Ingredient: HEPARIN SODIUM
Proprietary Name: LIPO-HEPIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 20,000 UNITS/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017027
Product Number: 007
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: 3M PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
LIPO-HEPIN (HEPARIN SODIUM)
Proprietary Name: LIPO-HEPIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 20,000 UNITS/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017027
Product Number: 007
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: 3M PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
20,000 UNITS/0.5ML
Marketing Status: Discontinued
Active Ingredient: HEPARIN SODIUM
Proprietary Name: LIPO-HEPIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 20,000 UNITS/0.5ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017027
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: 3M PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
LIPO-HEPIN (HEPARIN SODIUM)
Proprietary Name: LIPO-HEPIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 20,000 UNITS/0.5ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017027
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: 3M PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
40,000 UNITS/ML
Marketing Status: Discontinued
Active Ingredient: HEPARIN SODIUM
Proprietary Name: LIPO-HEPIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 40,000 UNITS/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017027
Product Number: 005
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: 3M PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: LIPO-HEPIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 40,000 UNITS/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017027
Product Number: 005
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: 3M PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information